196 related articles for article (PubMed ID: 28248797)
1. Metachronous Involvement, Diagnostic Imprecision of Serum Immunoglobulin G4 Levels, and Discordance Between Clinical and Radiological Findings in Immunoglobulin G4-Related Pachymeningitis: A Longitudinal Case Report.
Waheed W; Skidd PM; Borden NM; Gibson PC; Babi MA; Tandan R
J Clin Rheumatol; 2017 Jun; 23(4):215-221. PubMed ID: 28248797
[TBL] [Abstract][Full Text] [Related]
2. IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment.
Lu LX; Della-Torre E; Stone JH; Clark SW
JAMA Neurol; 2014 Jun; 71(6):785-93. PubMed ID: 24733677
[TBL] [Abstract][Full Text] [Related]
3. [Multiple cranial neuropathies in a patient with IgG4-related hypertrophic pachymeningitis: a case report].
Tsugawa J; Ouma S; Fukae J; Tsuboi Y; Sakata N; Inoue T
Brain Nerve; 2014 Jul; 66(7):873-8. PubMed ID: 24998832
[TBL] [Abstract][Full Text] [Related]
4. Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report.
Ueda K; Ikeda K; Ogawa K; Sukegawa M; Sano T; Kimura S; Suzuki O; Hashimoto Y; Takeishi Y
J Med Case Rep; 2016 Aug; 10(1):236. PubMed ID: 27557810
[TBL] [Abstract][Full Text] [Related]
5. Addition of second-line steroid sparing immunosuppressants like mycophenolate mofetil improves outcome of Immunoglobulin G4-related disease (IgG4-RD): a series from a tertiary care teaching hospital in South India.
Gupta N; Mathew J; Mohan H; Chowdhury SD; Kurien RT; Christopher DJ; Thangakunam B; Alexander M; Sivadasan A; Tamilarasi V; Valson AT; Gowri M; Kabeerdoss J; Danda D
Rheumatol Int; 2018 Feb; 38(2):203-209. PubMed ID: 28550399
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin-G4-related hypertrophic pachymeningitis with antineutrophil cytoplasmatic antibodies effectively treated with rituximab.
Popkirov S; Kowalski T; Schlegel U; Skodda S
J Clin Neurosci; 2015 Jun; 22(6):1038-40. PubMed ID: 25861887
[TBL] [Abstract][Full Text] [Related]
7. Hypertrophic pachymeningitis due to IgG4-related disease (RD-IgG4). A case report.
Sergio P; Alejandro R; Cristian F
Reumatol Clin (Engl Ed); 2023; 19(6):338-344. PubMed ID: 37179159
[TBL] [Abstract][Full Text] [Related]
8. Treatment of IgG4-related pachymeningitis in a patient with steroid intolerance: The role of early use of rituximab.
Gospodarev V; Câmara J; Chakravarthy V; Perry A; Wood M; Dietz R; Wang J; De Los Reyes K; Raghavan R
J Neuroimmunol; 2016 Oct; 299():62-65. PubMed ID: 27725123
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin G4-related spinal pachymeningitis.
Alrashdi MN
Saudi Med J; 2020 Jun; 41(6):652-656. PubMed ID: 32518934
[TBL] [Abstract][Full Text] [Related]
10. IgG4-related leptomeningitis: a reversible cause of rapidly progressive cognitive decline.
Mehta SH; Switzer JA; Biddinger P; Rojiani AM
Neurology; 2014 Feb; 82(6):540-2. PubMed ID: 24384648
[TBL] [Abstract][Full Text] [Related]
11. Polycystic subdural hygroma associated with immunoglobulin G4-related intracranial hypertrophic pachymeningitis: a case report.
Ota K; Nakazato Y; Okuda R; Yokoyama R; Kawasaki H; Tamura N; Yamamoto T
BMC Neurol; 2020 Jun; 20(1):228. PubMed ID: 32498716
[TBL] [Abstract][Full Text] [Related]
12. Hypertrophic pachymeningitis and tracheobronchial stenosis in IgG4-related disease: case presentation and literature review.
Yamashita H; Takahashi Y; Ishiura H; Kano T; Kaneko H; Mimori A
Intern Med; 2012; 51(8):935-41. PubMed ID: 22504255
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of IgG4 Indices in IgG4-related hypertrophic pachymeningitis.
Della-Torre E; Galli L; Franciotta D; Bozzolo EP; Briani C; Furlan R; Roveri L; Sessa M; Passerini G; Sabbadini MG
J Neuroimmunol; 2014 Jan; 266(1-2):82-6. PubMed ID: 24289956
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal rituximab in immunoglobulin G4-hypertrophic pachymeningitis.
Soares C; Martins DF; Pestana-Silva R; Honavar M; Faria O; Abreu P; Costa A
J Neuroimmunol; 2019 Sep; 334():576997. PubMed ID: 31254930
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal rituximab for IgG
Della-Torre E; Campochiaro C; Cassione EB; Albano L; Gerevini S; Bianchi-Marzoli S; Bozzolo E; Passerini G; Lanzillotta M; Terreni M; Callea M; Trimarchi M; Mortini P; Tresoldi M; Acerno S; Dagna L
J Neurol Neurosurg Psychiatry; 2018 Apr; 89(4):441-444. PubMed ID: 28819060
[No Abstract] [Full Text] [Related]
16. Idiopathic hypertrophic pachymeningitis: an autoimmune IgG4-related disease.
De Virgilio A; de Vincentiis M; Inghilleri M; Fabrini G; Conte M; Gallo A; Rizzo MI; Greco A
Immunol Res; 2017 Feb; 65(1):386-394. PubMed ID: 27592235
[TBL] [Abstract][Full Text] [Related]
17. IgG4-Related Hypertrophic Pachymeningitis at the Falx Cerebrii with Brain Parenchymal Invasion: A Case Report.
Li LF; Tse PY; Tsang FC; Lo RC; Lui WM; Leung GK
World Neurosurg; 2015 Aug; 84(2):591.e7-10. PubMed ID: 25836267
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin G4-related hypertrophic pachymeningitis: A case-oriented review.
Levraut M; Cohen M; Bresch S; Giordana C; Burel-Vandenbos F; Mondot L; Sedat J; Fontaine D; Bourg V; Martis N; Lebrun-Frenay C
Neurol Neuroimmunol Neuroinflamm; 2019 Jul; 6(4):e568. PubMed ID: 31355304
[TBL] [Abstract][Full Text] [Related]
19. [Pachymeningitis associated with IgG4 disease].
Zimelewicz Oberman D; Cuello Oderiz C; Baccanelli M; Christiansen S; Zurrú MC
Medicina (B Aires); 2017; 77(3):242-244. PubMed ID: 28643686
[TBL] [Abstract][Full Text] [Related]
20. Probable IgG4-related pachymeningitis: a case with transverse sinus obliteration.
Tanboon J; Felicella MM; Bilbao J; Mainprize T; Perry A
Clin Neuropathol; 2013; 32(4):291-7. PubMed ID: 23320997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
